222 related articles for article (PubMed ID: 22727330)
1. Stronger Toll-like receptor 1/2, 4, and 7/8 but less 9 responses in peripheral blood mononuclear cells in non-infectious exacerbated asthmatic children.
Lee WI; Yao TC; Yeh KW; Chen LC; Ou LS; Huang JL;
Immunobiology; 2013 Feb; 218(2):192-200. PubMed ID: 22727330
[TBL] [Abstract][Full Text] [Related]
2. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
4. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
5. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
6. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
[TBL] [Abstract][Full Text] [Related]
7. Maturation of Toll-like receptor 1-4 responsiveness during early life.
Liao SL; Yeh KW; Lai SH; Lee WI; Huang JL
Early Hum Dev; 2013 Jul; 89(7):473-8. PubMed ID: 23591080
[TBL] [Abstract][Full Text] [Related]
8. Expression of Toll-like receptors by neonatal leukocytes.
Dasari P; Zola H; Nicholson IC
Pediatr Allergy Immunol; 2011 Mar; 22(2):221-8. PubMed ID: 21054549
[TBL] [Abstract][Full Text] [Related]
9. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations.
van den Biggelaar AH; Prescott SL; Roponen M; Nadal-Sims MA; Devitt CJ; Phuanukoonnon S; Pomat W; Tulic MK; Lehmann D; Siba PM; Richmond PC; Holt PG
J Allergy Clin Immunol; 2009 Sep; 124(3):544-50, 550.e1-2. PubMed ID: 19500827
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells.
Corbett NP; Blimkie D; Ho KC; Cai B; Sutherland DP; Kallos A; Crabtree J; Rein-Weston A; Lavoie PM; Turvey SE; Hawkins NR; Self SG; Wilson CB; Hajjar AM; Fortuno ES; Kollmann TR
PLoS One; 2010 Nov; 5(11):e15041. PubMed ID: 21152080
[TBL] [Abstract][Full Text] [Related]
11. Breastfeeding modulates neonatal innate immune responses: a prospective birth cohort study.
Belderbos ME; Houben ML; van Bleek GM; Schuijff L; van Uden NO; Bloemen-Carlier EM; Kimpen JL; Eijkemans MJ; Rovers M; Bont LJ
Pediatr Allergy Immunol; 2012 Feb; 23(1):65-74. PubMed ID: 22103307
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients.
Chen Z; Cheng Y; Xu Y; Liao J; Zhang X; Hu Y; Zhang Q; Wang J; Zhang Z; Shen F; Yuan Z
Clin Immunol; 2008 Sep; 128(3):400-8. PubMed ID: 18565796
[TBL] [Abstract][Full Text] [Related]
13. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.
Wang JP; Zhang Y; Wei X; Li J; Nan XP; Yu HT; Li Y; Wang PZ; Bai XF
APMIS; 2010 Apr; 118(4):261-70. PubMed ID: 20402671
[TBL] [Abstract][Full Text] [Related]
14. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
[TBL] [Abstract][Full Text] [Related]
15. Toll like receptor 2 agonists lipoteichoic acid and peptidoglycan are able to enhance antigen specific IFNγ release in whole blood during recall antigen responses.
Dammermann W; Wollenberg L; Bentzien F; Lohse A; Lüth S
J Immunol Methods; 2013 Oct; 396(1-2):107-15. PubMed ID: 23954282
[TBL] [Abstract][Full Text] [Related]
16. Multiplex analysis of toll-like receptor-stimulated neonatal cytokine response.
Caron JE; La Pine TR; Augustine NH; Martins TB; Hill HR
Neonatology; 2010; 97(3):266-73. PubMed ID: 19955831
[TBL] [Abstract][Full Text] [Related]
17. CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
Buza J; Benjamin P; Zhu J; Wilson HL; Lipford G; Krieg AM; Babiuk LA; Mutwiri GK
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):273-82. PubMed ID: 18789542
[TBL] [Abstract][Full Text] [Related]
18. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.
Mao TK; Lian ZX; Selmi C; Ichiki Y; Ashwood P; Ansari AA; Coppel RL; Shimoda S; Ishibashi H; Gershwin ME
Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622
[TBL] [Abstract][Full Text] [Related]
19. Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics.
Pace E; Di Sano C; Ferraro M; Bruno A; Caputo V; Gallina S; Gjomarkaj M
Pulm Pharmacol Ther; 2015 Jun; 32():93-100. PubMed ID: 25722071
[TBL] [Abstract][Full Text] [Related]
20. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides.
Sackesen C; van de Veen W; Akdis M; Soyer O; Zumkehr J; Ruckert B; Stanic B; Kalaycı O; Alkan SS; Gursel I; Akdis CA
Allergy; 2013; 68(5):593-603. PubMed ID: 23480796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
